Caravaca F, Arrobas M, Pizarro J L, Cancho B, Cubero J J, Espárrago J F, García M C, Sánchez-Casado E
Servicio de Nefrología, Hospital Infanta Cristina, 06080 Badajoz.
Nefrologia. 2001 May-Jun;21(3):274-82.
The mortality among end-stage renal failure (ESRF) patients undergoing renal replacement therapy (RRT) remains high. An important proportion of these patients die shortly after the initiation of RRT. The present study aims to determine the best predictors for the early mortality in a group of 140 ESRF patients who initiated RRT between october 96 and december 99. The mean age of the study group was 61 +/- 13 years, and the mean follow-up time was 20 +/- 12 months. Diabetic nephropathy was the most prevalent etiology of renal failure (30%). The following data, collected immediately before the initiation of RRT, were included as independent variables: demographic and clinical characteristics, including the nutritional status established by the Subjective Global Assessment (SGA), follow-up time in the predialysis clinic (less or longer than 3 months), EPO therapy, vascular access, renal function (creatinine and urea clearances, and Kt/V urea), hematological and biochemical data including serum albumin, bicarbonate, transferrin, PTH and C-Reactive protein, as well as the protein catabolic rate and the percent of lean body mass normalized for ideal body weight, calculated from the 24 h total urine excretion of nitrogen and creatinine. The Cox proportional hazard regression model, stratified for an age over or less than 65 year, was utilized to determine the best predictors for the mortality during the study period. Sixty percent of patients had at least one comorbid condition, and 35% had cardiovascular diseases. Mild-moderate or severe malnutrition was observed in 48% of patients. The creatinine clearance and Kt/V urea before the initiation of RRT were: 9.50 +/- 2.64 ml/min/1.73 m2 and 1.47 +/- 0.44, respectively. Forty-one patients died during the study period (annual death rate: 17%). The best predictor of mortality was the nutritional status assessed by the SGA (OR: 2.32, IC 95% 1.54-3.48, p < 0.0001). In a second analysis in which the SGA was removed from the model, the previous history of cardiovascular diseases (OR: 2.07, CI 95%: 1.06-4.06, p = 0.032), and the percent of lean body mass/ideal weight (OR: 0.96; IC 95%: 0.93-0.99; p = 0.042), proved to be the best predictor of mortality. In conclusion, nutritional indices prior to the initiation of RRT, and the previous history of cardiovascular diseases were the best predictors of the early mortality in this unselected population on dialysis. Because nutritional status appeared to be a marker of the severity of the comorbid conditions, a better control of the number and severity of these comorbid conditions may be the best way for reducing the mortality in patients on RRT.
接受肾脏替代治疗(RRT)的终末期肾衰竭(ESRF)患者死亡率仍然很高。这些患者中有很大一部分在开始RRT后不久就死亡。本研究旨在确定1996年10月至1999年12月期间开始接受RRT的140例ESRF患者早期死亡的最佳预测因素。研究组的平均年龄为61±13岁,平均随访时间为20±12个月。糖尿病肾病是肾衰竭最常见的病因(30%)。在开始RRT之前立即收集的以下数据作为自变量:人口统计学和临床特征,包括通过主观全面评定法(SGA)确定的营养状况、透析前门诊的随访时间(少于或超过3个月)、促红细胞生成素治疗、血管通路、肾功能(肌酐和尿素清除率以及尿素Kt/V)、血液学和生化数据,包括血清白蛋白、碳酸氢盐、转铁蛋白、甲状旁腺激素和C反应蛋白,以及根据24小时尿氮和肌酐总排泄量计算的蛋白质分解代谢率和相对于理想体重的瘦体重百分比。采用Cox比例风险回归模型,按年龄大于或小于65岁进行分层,以确定研究期间死亡率的最佳预测因素。60%的患者至少有一种合并症,35%患有心血管疾病。48%的患者观察到轻度 - 中度或重度营养不良。开始RRT前的肌酐清除率和尿素Kt/V分别为:9.50±2.64 ml/min/1.73 m2和1.47± .44。41例患者在研究期间死亡(年死亡率:17%)。死亡率的最佳预测因素是通过SGA评估所得的营养状况(比值比:2.32,95%置信区间1.54 - 3.48,p < 0.0001)。在第二项分析中,将SGA从模型中去除后,心血管疾病既往史(比值比:2.07,95%置信区间:1.06 - 4.06,p = 0.032)以及瘦体重/理想体重百分比(比值比:0.96;95%置信区间:0.93 - 0.99;p = 0.042)被证明是死亡率的最佳预测因素。总之,RRT开始前的营养指标以及心血管疾病既往史是这一未经过筛选的透析人群早期死亡的最佳预测因素。由于营养状况似乎是合并症严重程度的一个指标,更好地控制这些合并症的数量和严重程度可能是降低接受RRT患者死亡率的最佳方法。